Johnson & Johnson vs Invesco WilderHill Clean Energy ETF — how do they compare? Johnson & Johnson trades at $260.55 (market cap $626.09B), while Invesco WilderHill Clean Energy ETF trades at $34.86. The key difference: Johnson & Johnson pays a 2.06% dividend while Invesco WilderHill Clean Energy ETF pays none, and Johnson & Johnson is trading nearer its 52-week high, Invesco WilderHill Clean Energy ETF nearer its low. Which is the better fit depends on your goals.
| JNJ | PBW | |
|---|---|---|
Market Cap | $626.09B | — |
Volume | 6,156,228 | — |
Sector | Health | Sector/Thematic |
52-Week High | $267.24 | $46.99 |
52-Week Low | $172.78 | $24.14 |
Enterprise Value | $654.37B | — |
Dividend Yield | 2.06% | — |
Signals from Pluang's Aura AI — not financial advice
Johnson & Johnson (JNJ) trades at $261.26, down 0.21% on the day, near its 52-week high. The stock shows a bullish technical trend with strong moving averages and recent earnings beats. Revenue grew to $94.19B in 2025, with a net income margin of 21.48%, though cash flow turned negative due to heavy investing. The company maintains a robust dividend history, with consistent payouts and a 64-year growth streak.
Outlook remains positive with a consensus price target of $284.50, offering ~9% upside. Risks include legal headwinds and patent expirations, but analyst sentiment is bullish (52.5% buy ratings). JNJ's defensive profile and pipeline strength support long-term growth, though investors should monitor debt levels, which rose to 24.06% of assets in 2025.
PBW trades at $34.93, up 0.92% today, with a bullish technical signal from moving averages but neutral oscillators. The ETF benefits from clean energy tailwinds, including rising global investment and energy security concerns, yet lacks disclosed fundamental ratios. Recent news highlights volatility linked to interest rate movements and sector rotations.
Outlook is mixed: clean energy demand offers growth potential, but sensitivity to Treasury yields and tech sell-offs poses risks. Investors face upside from policy support offset by macroeconomic headwinds and valuation uncertainties due to missing financial data.
Trailing returns across standard periods
Latest headlines on both assets
Johnson & Johnson manufactures health care products and provides related services for the consumer, pharmaceutical, and medical devices and diagnostics markets. The Company sells products such as skin and hair care products, acetaminophen products, pharmaceuticals, diagnostic equipment, and surgical equipment in countries located around the world.
Read more on JNJ →PBW is an equal-weighted ETF that invests in U.S. companies leading the clean energy transition. It focuses on renewable energy, power conservation, and sustainable technologies like solar, wind, and energy storage.
Read more on PBW →